Spending and Utilization on Drugs Prescribed by Otolaryngologists to Medicare Beneficiaries, 2013 to 2017.
Shivani A ShahLauren E MillerRoy XiaoAlan WorkmanLucy J XuVinay K RathiPublished in: The Annals of otology, rhinology, and laryngology (2021)
Spending on drugs prescribed by otolaryngologists to Medicare Part D beneficiaries declined between 2013 and 2017 in part due to a transition from brand name drugs to lower-cost generic equivalents.
Keyphrases